Your session is about to expire
← Back to Search
Device
Intervention for Type 2 Diabetes
N/A
Waitlist Available
Research Sponsored by Abbott Diabetes Care
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up six (6) months
Awards & highlights
Study Summary
This trial will compare the weight-loss effects of the FreeStyle Libre 2 system to the current standard of care for diabetes monitoring.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ six (6) months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~six (6) months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Difference in bodyweight from the control arm at 6 months
Trial Design
2Treatment groups
Active Control
Group I: Standard of CareActive Control1 Intervention
No intervention will be administered. Subjects randomized to the Standard of Care Arm will continue using their Current standard of care device to monitor and manage their diabetes
Group II: InterventionActive Control1 Intervention
Subjects randomized to this Arm will use FreeStyle Libre 2 to monitor and manage their diabetes.
Find a Location
Who is running the clinical trial?
Abbott Diabetes CareLead Sponsor
63 Previous Clinical Trials
24,726 Total Patients Enrolled
Shridhara A Karinka, PhDStudy DirectorAbbott Diabetes Care
9 Previous Clinical Trials
2,748 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger